Seoul, South Korea

Dong Hwan Kim

USPTO Granted Patents = 50 

 

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 132(Granted Patents)

Forward Citations (Not Self Cited) = 130(Oct 12, 2025)


Location History:

  • Seoul KR (1996)
  • Gyunggi-do, KR (2014 - 2015)
  • Seoul, KR (1998 - 2024)

Company Filing History:

goldMedal22 out of 22 
 
42 Maru Inc.
 patents
silverMedal7 out of 2,164 
 
Korea Institute of Science and Technology
 patents
bronzeMedal5 out of 7,574 
 
Samsung Electro-mechanics Co., Ltd.
 patents
43 out of 1,333 
 
Yonsei University
 patents
52 out of 94 
 
Humax Co., Ltd.
 patents
62 out of 131,214 
 
Samsung Electronics Co., Ltd.
 patents
72 out of 2,607 
 
Korea Advanced Institute of Science and Technology
 patents
82 out of 18,523 
 
Hyundai Motor Company
 patents
91 out of 6 
 
Korea Information & Communication Co., Ltd.
 patents
101 out of 376 
 
Dongwoo Fine-chem Co., Ltd.
 patents
111 out of 5 
 
Korea Chungang Educational Foundation
 patents
121 out of 159 
 
Kyungdong Navien Co., Ltd.
 patents
131 out of 47 
 
Seoyon E-hwa Co., Ltd.
 patents
141 out of 1 
 
Humaccos Co., Ltd.
 patent
151 out of 2 
 
Rayir, Co.
 patents
161 out of 4,013 
 
Kia Corporation
 patents
171 out of 29 
 
Daechang Seat Co.,ltd-dongtan
 patents
181 out of 183 
 
Hyundai Transys Incorporated
 patents
191 out of 8,087 
 
Kia Motors Corporation
 patents
201 out of 5,362 
 
Lg Innotek Co., Ltd.
 patents
212 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1996-2025

Loading Chart...
Loading Chart...
50 patents (USPTO):Explore Patents

Dong Jin Kim is a renowned inventor and patent holder hailing from Seoul, South Korea. With a total of 635 patents to his name, his contributions to the field of innovation and invention are unmatched. Mr. Kim's latest patents include an alpha-aminoamide derivative compound and a passenger hand-luggage checking system and method for airports.

The alpha-aminoamide derivative compound has potential therapeutic applications. It acts as a reversible inhibitor of MAO-B, a common target for many drugs used in the treatment of various neurological and psychiatric disorders. Unlike existing drugs that use irreversible inhibitors, this compound can alleviate or eliminate the side effects of existing drugs acting via a covalent bond with MAO-B. This novel compound is superior in stability and efficacy compared to other reversible inhibitors, providing significant benefits for the treatment of neurological and psychiatric disorders.

The second patent secured by Mr. Kim is an innovative passenger hand-luggage checking system and method for airports. The system includes a platform to load a passenger hand luggage, a weight and size measurer to determine the weight and size of the luggage and an allowance-information provider to provide allowance information. The system also includes a regulation-based determiner that compares the weight and size of the passenger's luggage with the allowance allowed and provides check-out information about whether the luggage is within the allowed baggage limit. This inventive system enhances airport security measures and enables efficient processing at airport checkpoints.

Mr. Kim worked in renowned companies such as NeuroBiogen Co., Ltd. and CAS Corporation and collaborated with some notable coworkers such as Jae Hyun Lim and Hee Suk Pang. His groundbreaking patents impressively showcase his commitment to innovation and invention.

In conclusion, Dong Jin Kim has been a key figure in the field of innovation and patents, with numerous patents to his name. His newest patents address the latest challenges in the fields of medicine and security, highlighting his commitment to finding new solutions to old problems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…